This site uses cookies, including third-party cookies, that help us to provide and improve our services. Read More

Rhizoma Gastrodiae Tablets Market

Rhizoma Gastrodiae Tablets Market

Rhizoma Gastrodiae Tablets Market, Forecast, Trend, Analysis & Competition Tracking - Global Market Insights 2021 to 2031

Rhizoma Gastrodiae Tablets Market
FACT6322MR
  • Jun-2021
  • List of Tables : 25
  • List of Figures : 132
  • 170 Pages
  • Healthcare

Key Questions Answered in Report

  • What are the growth prospects for rhizoma gastrodiae tablets market from 2021-2031?

    According to Fact. MR’s analysis, demand for rhizoma gastrodiae tablets is anticipated to witness a considerable incline from 2021 to 2031 and expand at a CAGR exceeding 10%. Extensive uptake to treat chronic ailments such as liver disorders will greatly

  • Which country will generate the most promising expansion opportunities for rhizoma gastrodiae tablet manufacturers?

    China is likely to emerge as the center-stage for enhanced sales of rhizoma gastrodiae tablets, expected to generate over 50% of total revenue from 2021 to 2031. Simultaneously, India is anticipated to experience a surge of 9% CAGR across the aforemention

  • Which type of rhizoma gastrodiae tablets are expected to generate maximum demand through 2031?

    Fact.MR anticipates demand for gastrodia elata f. glauca rhizoma gastrodiae tablets to surge at a staggering 10% CAGR over the next ten years.

Report Also Addresses:

  • Market Estimates and Forecasts (2016-2031)
  • Key Drivers and Restraints Shaping Market Growth
  • Segment-wise, Country-wise, and Region-wise Analysis
  • Competition Mapping and Benchmarking
  • Brand Share and Market Share Analysis
  • Key Product Innovations and Regulatory Climate
  • COVID-19 Impact on Rhizoma Gastrodiae Tablets and How to Navigate
  • Recommendation on Key Winning Strategies

Know More Details About the Report

Demand for Rhizoma Gastrodiae Tablets from 2016 to 2020 Vs Future Market Projections for 2021-2031

From 2016 to 2020, sales of rhizoma gastrodiae tablets were significantly high, expanding at under 10% CAGR. Increasing preference for traditional and alternative medicine over conventional allopathic ones amid rising health concerns has been driving majority of market growth.

The COVID-19 pandemic has promised significant future expansion prospects, as key healthcare providers seek to incorporate natural alternatives to reduce inflammation episodes. From 2021 to 2031, demand is likely expand at a CAGR exceeding 10% as key regions incorporate plant-based medicine to address such key problems as liver diseases.

How is Demand for Plant-based Medicine Spurring Rhizoma Gastrodiae Tablet Sales?

Traditional herbal medicines are acquiring significant attention in the global healthcare industry. Data from the World Health Organization (W.H.O) concludes that traditional herbal medicine was effectively used to treat severe acute respiratory syndrome (SARS) in China, while 80% of Africans deployed various forms of herbal medicine.

Worldwide annual market for these products is currently valued at US$ 60 billion, and it is anticipated that traditional herbal medicine will make significant strides in the global market, with countries such as China, India, Nigeria and the U.S expected to make significant strides, eventually heightening prospects for rhizoma gastrodiae tablets.

Avail customized purchase options for your needs

Increasing Prevalence of Liver Disorders Opening Up New Frontiers for Rhizoma Gastrodiae Tablets?

Liver disease accounts for approximately 2 million deaths annually worldwide, half of them due to complications arising out of cirrhosis and the balance as a result of viral hepatitis and hepatocellular carcinoma, according to the National Center for Biotechnology Information.

Moreover, about 2 billion people consume alcohol worldwide and upwards of 75 million are diagnosed with alcohol-use disorders and are at risk of alcohol-associated liver disease. In addition, a significant chunk of the population also lives with fatty liver. Hence, rhizoma gastrodiae tablets are likely to prove useful in mitigating these diseases, inclining their demand.

What are the Key Challenges to Market Expansion for Manufacturers of Rhizoma Gastrodiae Tablets?

A major challenge expected to hamper sales of rhizoma gastrodiae tablets is the limited presence of adequate manufacturers. Currently, bulk of all products manufacturing is restricted to China, attributed to the presence of regional level players.

However, certain players are attempting to expand their business in overseas markets in order to expand their geographical footprint, widening expansion prospects. Another challenge is that of regulatory approvals. Due to availability of limited literature, key authorities are unable to ascertain their effectiveness, delaying product launches.

rhizoma gastrodiae tablets market

An Adaptive Approach to Modern-day Research Needs

Country-wise Analysis

How is Growing Popularity of Alternative Medicine Bolstering Rhizoma Gastrodiae Tablet Sales in the U.S.?

The market for rhizoma gastrodiae tablets in the U.S is likely to expand at under 5% CAGR until 2031. Increasing preference for herbal medicines over conventional ones is largely attributed as the chief growth driver for the region.

According to the American Botanical Council, sales of herbal products exceeded US$ 5.3 billion as of the beginning of the previous decade, climbing by 8% to reach around US$ 6 billion by 2013. It further rose to over US$ 9 billion in 2019. Hence, prospects for these medicines appear highly bright across the U.S

Why is Demand for Rhizoma Gastrodiae Tablets High in China?

China is expected to remain the epicenter for global rhizoma gastrodiae tablets, generating more than 50% of the revenue share across the forecast period. Extensive development of Traditional Chinese Medicine (TCM) underpins majority of the East Asian giant’s market growth prospects.

A plethora of chronic ailments have been addressed in China by virtue of traditional herbal-based medicine. As per the World Health Organization (W.H.O), TCM accounts for around 40% of all healthcare delivered. Hence, a number of regional level manufacturers have emerged across key provinces.

How are Growth Prospects for Rhizoma Gastrodiae Tablets Surging in India?

India is poised to exhibit a robust 9% CAGR with respect to rhizoma gastrodiae tablets sales in forthcoming years. The Indian Journal of Pharmacology estimates that 60% of registered physicians are involved in traditional and alternate systems of medicine in India.

Additionally, there are about 700,000 registered practitioners of traditional medicine, majority in Ayurveda, and around 650,000 registered practitioners of modern medicine in India. Also, heightening concerns over allopathic medicines on overall health is also spurring demand for natural medicines, thus providing impetus to market growth.

Category-wise Analysis

Why are Gastrodia Elata F. Glauca Rhizoma Gastrodiae Tablets Highly Preferred?

By type, demand for gastrodia elata f. glauca rhizoma gastrodiae tablets is likely to witness an impressive incline, at a staggering 10% CAGR until 2031. These tablets have proven highly effective in addressing a variety of ailments.

Gastrodia elata. f. glauca derived rhizoma gastrodiae tablets has been used to treat conditions such as headache, dizziness, convulsion, paralysis, rheumatism, epilepsy, strokes, spasms and lumbago.

Have a report related query? Speak to us directly

Competitive Landscape

The rhizoma gastrodiae tablets landscape appears highly consolidated, with a major chunk of it being dominated by Chinese players. Some notable developments in the market include:

  • In June 2017, Beijing Tong Ren Tang Europe Holding B.V entered a strategic co-operation agreement with the Republic of Kazakhstan for establishing a Chinese Medical Center to further Chinese Medicine
  • In November 2019, Tsumura & Co. concluded its Letter of Intent regarding Tianjin China Medico Technology Co. Ltd. to forge a capital alliance with the intention of expanding its business in Traditional Chinese Medicine and ensure stable supply of crude drugs

*This list is indicative- full details about prominent rhizoma gastrodiae tablets manufacturers is available upon request.

Report Scope

Attribute

Details

Forecast Period

2021-2031

Historical Data Available for

2016-2020

Market Analysis

US$ Mn for Value & ‘000 Units for Volume

Key Regions Covered

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East & Africa

Key Countries Covered

  • U.S.
  • Canada
  • Brazil
  • Mexico
  • Argentina
  • Germany
  • U.K.
  • France
  • Spain
  • Italy
  • Japan
  • China
  • South Korea
  • India
  • ASEAN
  • Australia & New Zealand
  • GCC
  • South Africa

Key Segments Covered

  • Type
  • Application
  • Region

Key Companies Profiled

  • Zhaotong Huacheng Pharmaceuticals
  • Guangdong Luofu Shan National Pharmaceutical Co. Ltd.
  • Beijing Tong Ren Tang
  • Guizhou Bailing Group
  • Guangxi Changzhou Natural Pharmaceutical Co. Ltd.
  • Lanzhou Foci Pharmaceutical
  • Shaanxi Tianyang Pharmaceutical
  • Taiji Group Sichuan Mianyang Pharmaceutical
  • Tsumura & Co.

Pricing

Available upon Request

Key Market Segments Covered

  • Type

    • Gastrodia Elata F. Glauca Rhizoma Gastrodiae Tablets
    • G. Elata Bl. F. Elta Rhizoma Gastrodiae Tablets
    • Other Rhizoma Gastrodiae Tablets
  • Distribution Channel

    • Rhizoma Gastrodiae Tablets for Hospital Pharmacies
    • Rhizoma Gastrodiae Tablets for Retail Pharmacies
    • Rhizoma Gastrodiae Tablets for Online Pharmacies
  • Region

    • North America
      • U.S.
      • Canada
    • Latin America
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
    • Europe
      • Germany
      • U.K.
      • France
      • Spain
      • Italy
      • Rest of Europe
    • East Asia
      • China
      • Japan
      • South Korea
      • Rest of East Asia
    • South Asia
      • India
      • ASEAN
      • Rest of South Asia
    • Middle East & Africa
      • GCC
      • South Africa
      • Rest of MEA
    • Oceania
      • Australia & New Zealand
      • Rest of Oceania

Rhizoma Gastrodiae Tablets Market Report Scope

A recent study by Fact.MR on the rhizoma gastrodiae tablets market offers a 10-year forecast for 2021 to 2031. The study analyzes crucial trends that are currently determining the growth of the market. This report explicates on vital dynamics, such as the drivers, restraints, and opportunities for key market players along with key stakeholders as well as emerging players associated with offering rhizoma gastrodiae tablets.

The study also provides the dynamics responsible for influencing the future status of the market over the forecast period. A detailed assessment of value chain analysis, business execution, and supply chain analysis across regional markets has been covered in the report.

A list of prominent companies manufacturing rhizoma gastrodiae tablets, along with their product portfolios, enhances the reliability of this comprehensive research study.

Report Summary

The study offers comprehensive analysis on diverse features, including production capacities, demand, product developments, revenue generation, and sales of rhizoma gastrodiae tablets across the globe.

A comprehensive estimate on the market has been provided through an optimistic as well as a conservative scenario, taking into account the sales of rhizoma gastrodiae tablets during the forecast period. Price point comparison by region with global average price is also considered in the study.

Key Questions Answered in Report

  • Which are the most lucrative markets for rhizoma gastrodiae tablets?
  • Which factors will impact the growth of the rhizoma gastrodiae tablets market?
  • How will changing trends impact the strategies of market players?
  • How can market players capture the low-hanging opportunities across regions?
  • Which companies are leading the rhizoma gastrodiae tablets industry?
  • What are the winning strategies of stakeholders in the market?

Analysis on Market Size Evaluation

The market has been analyzed for each segment in terms of volume (‘000 Units) and value (US$ Mn).

Market estimates at global and regional levels for rhizoma gastrodiae tablets are available in terms of “US$ Mn” for value and in “000 Units” for volume. A Y-o-Y growth contrast on prominent market segments, along with market attractiveness evaluation, has been incorporated in the report. Furthermore, absolute dollar opportunity analysis of all the segments adds prominence to the report. Absolute dollar opportunity plays a crucial role in assessing the level of opportunity that a manufacturer/distributor can look to achieve, along with identifying potential resources, considering the sales and distribution perspective in the global rhizoma gastrodiae tablets market.

Inspected Assessment on Regional Segments

Key sections have been elaborated in the report, which have helped deliver projections on regional markets. These chapters include regional macros (political, economic, and business environment outlook), which are expected to have a momentous influence on the growth of the market during the forecast period.

Country-specific valuation on demand for rhizoma gastrodiae tablets has been offered for each region, along with market scope estimates and forecasts, price index, and impact analysis of the dynamics of prominence in regions and countries. For all regional markets, Y-o-Y growth estimates have also been incorporated in the report.

Detailed breakup in terms of value and volume for emerging countries has also been included in the report.

In-depth Analysis on Competitive Landscape

The report sheds light on leading manufacturers of rhizoma gastrodiae tablets, along with their detailed profiles. Essential and up-to-date data related to market performers who are principally engaged in offering rhizoma gastrodiae tablets has been brought with the help of a detailed dashboard view. Market share analysis and comparison of prominent players provided in the report permits report readers to take preemptive steps in advancing their businesses.

Research Methodology

In Fact.MR’s study, a unique research methodology is utilized to conduct extensive research on the growth of the rhizoma gastrodiae tablets market, and reach conclusions on the future growth parameters. This research methodology is a combination of primary and secondary research, which helps analysts ensure the accuracy and reliability of the drawn conclusions.

Secondary resources referred to by analysts during the preparation of the market study include statistics from governmental organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, all of whom have contributed to the development of the research report as a primary resource.

- FAQs -

Demand for rhizoma gastrodiae tablets is anticipated to witness a considerable incline from 2021 to 2031 and expand at a CAGR exceeding 10%. Extensive uptake to treat chronic ailments such as liver disorders will greatly

China is likely to emerge as the center-stage for enhanced sales of rhizoma gastrodiae tablets, expected to generate over 50% of total revenue from 2021 to 2031. Simultaneously, India is anticipated to experience a surge of 9% CAGR across the afor

Demand for gastrodia elata f. glauca rhizoma gastrodiae tablets to surge at a staggering 10% CAGR over the next ten years.

Need an Exclusive Report for your Unique Requirement?

- Our Clients -

Report Client

- Evaluate How Fact.MR's Report Can Help. -

Is the market research conducted by Fact.MR?

Yes, the report has been compiled by expert analysts of Fact.MR, through a combination of primary and secondary research. To know more about how the research was conducted, you can speak to a research analyst.

What research methodology is followed by Fact.MR?

Fact.MR follows a methodology that encompasses the demand-side assessment of the market, and triangulates the same through a supply-side analysis. This methodology is based on the use of standard market structure, methods, and definitions.

What are the sources of secondary research?

Fact.MR conducts extensive secondary research through proprietary databases, paid databases, and information available in the public domain. We refer to industry associations, company press releases, annual reports, investor presentations, and research papers. More information about desk research is available upon request.

Who are the respondents for primary research?

Fact.MR speaks to stakeholders across the spectrum, including C-level executives, distributors, product manufacturers, and industry experts. For a full list of primary respondents, please reach out to us.

Is a sample of this report available for evaluation?

Yes, you can request a sample, and it will be sent to you through an email.